Head-to-Head Preclinical Studies of SFA-002 as a Novel Psoriasis Treatment Presented at the ...
SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oral small-molecule biosynthetic ...
WKRN-TV9 天
Head-to-Head Preclinical Studies of SFA-002 as a Novel Psoriasis Treatment Presented at the ...
"Profiling of Apremilast and SFA-002 in an Imiquimod (IMQ) Mouse Model of Psoriasis," will be available at the poster viewing session area in the exhibition hall Friday, March 7, through Sunday ...
BioSpace9 天
Head-to-Head Preclinical Studies of SFA-002 as a Novel Psoriasis Treatment Presented at the ...
“Profiling of Apremilast and SFA-002 in an Imiquimod (IMQ) Mouse Model of Psoriasis,” will be available at the poster viewing session area in the exhibition hall Friday, March 7, through Sunday, March ...